You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mutant pro-urokinase

Showing 1 - 25 of 2,922
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ischemic Stroke Trial in Rotterdam (mutant pro-urokinase, Alteplase)

Recruiting
  • Ischemic Stroke
  • Rotterdam, Netherlands
    DUMAS trial office
Jun 17, 2021

Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
Jan 14, 2022

Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

Not yet recruiting
  • Low Grade Glioma of Brain
  • PEPIDH1M vaccine + vorasidenib
  • Durham, North Carolina
    Duke University Medical Center
Nov 2, 2022

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

Not yet recruiting
  • NSCLC Stage IV
  • KRAS P.G12C
  • Brussels, Belgium
  • +26 more
Jan 3, 2023

Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
May 23, 2022

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

Recruiting
  • Non-small Cell Lung Cancer
    • Guanzhou, China
      Sun Yat-sen University Cancer Center
    Aug 11, 2023

    NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • +3 more
    • San Antonio, Texas
    • +1 more
    Sep 8, 2023

    Cancer Trial in Philadelphia (Encounter-based PRO monitoring, Remote PRO monitoring)

    Not yet recruiting
    • Cancer
    • Encounter-based PRO monitoring
    • Remote PRO monitoring
    • Philadelphia, Pennsylvania
      Abramson Cancer Center
    Aug 24, 2023

    First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

    Completed
    • BRAF V600E Mutation Positive
    • Metastatic Colorectal Cancer
    • Non Interventional study
    • St. Veit/Glan, Austria
    • +33 more
    Jan 20, 2023

    Post Endodontic Pain Trial in Ajman (ProTaper Ultimate, ProTaper Gold)

    Recruiting
    • Post Endodontic Pain
    • ProTaper Ultimate
    • ProTaper Gold
    • Ajman, United Arab Emirates
      Gulf Medical University
    Feb 28, 2023

    COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

    Active, not recruiting
    • COVID-19
    • Inactivated COVID-19 Vaccine
    • Weihai, Shandong, China
      Rushan City Center for Disease Control and Prevention
    Jul 11, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

    Recruiting
    • H3 K27M
    • Glioma
    • Santa Monica, California
      Providence Saint John's Cancer Institute
    Nov 28, 2022

    Advanced Solid Tumor Trial in Shanghai (SY-5933)

    Recruiting
    • Advanced Solid Tumor
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 16, 2023

    HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Aurora, Colorado
    • +2 more
    Dec 29, 2022

    NSCLC Trial in Singapore (Oral S-1 + Oral Osimertinib)

    Not yet recruiting
    • NSCLC
    • Oral S-1 + Oral Osimertinib
    • Singapore, Singapore
      National Cancer Center Singapore
    Mar 6, 2023

    Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

    Not yet recruiting
    • Lung Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
    • New York, New York
      NYU Langone Health
    Apr 4, 2023

    Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
    • New York, New York
      NYU Langone Health
    Apr 4, 2023

    Exercise Trial in New York (Graded-Intensity Treadmill Exercise Protocol)

    Not yet recruiting
    • Exercise
    • Graded-Intensity Treadmill Exercise Protocol
    • New York, New York
      Tisch Hospital
    Jun 20, 2023

    Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

    Recruiting
    • Adult Gliomas, Mixed
    • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
    • Magnetic Resonance Image (MRI)
    • San Francisco, California
      University of California, San Francisco
    May 9, 2023